Mereo BioPharma Group Stock Forecast

MREO's stock price has decreased by -89.4% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 3 analysts that cover Mereo BioPharma Group stock have a consensus rating of "Buy" and an average price target of $1.50, which forecasts a 533.18% increase in the stock price over the next year. The lowest target is $0.50 and the highest is $3.00.

Price Target: $1.50 (+533.18%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$0.50	$1.50	$1.00	$3.00
Change	+111.06%	+533.18%	+322.12%	+1166.4%

Analyst Ratings

The average analyst rating for Mereo BioPharma Group stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	2	2	2	2	2	2
Buy	2	2	2	0	0	0
Hold	2	2	2	3	3	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	6	6	5	5	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Julian Harrison BTIG	BTIG	Strong Buy Reiterates $1	Strong Buy	Reiterates	$1	+322.12%	May 12, 2026
Priyanka Grover JP Morgan	JP Morgan	Buy → Hold Downgrades n/a	Buy → Hold	Downgrades	n/a	n/a	Mar 23, 2026
Julian Harrison BTIG	BTIG	Strong Buy Reiterates $1	Strong Buy	Reiterates	$1	+322.12%	Jan 16, 2026
Gil Blum Needham	Needham	Strong Buy Maintains $5 → $3	Strong Buy	Maintains	$5 → $3	+1,166.36%	Jan 13, 2026
Maury Raycroft Jefferies	Jefferies	Strong Buy → Hold Downgrades $7 → $0.5	Strong Buy → Hold	Downgrades	$7 → $0.5	+111.06%	Dec 30, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

33.03M

from 500.00K

6,505.40%

from 500.00K

Revenue Next Year

41.09M

from 33.03M

24.41%

from 33.03M

EPS This Year

-0.03

from -0.26

EPS Next Year

-0.00

from -0.03

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	49.37M	-	10.00M	-	500.00K	33.03M	41.09M
Revenue Growth	-	-	-	-	-	6,505.40%	24.41%
EPS	-0.31	-0.35	-0.22	-0.29	-0.26	-0.03	-0.00
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	9	8

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	52.5M	109.9M
Avg	33.0M	41.1M
Low	n/a	303,800

Revenue Growth

Revenue Growth	2026	2027
High	10,400.0%	232.7%
Avg	6,505.4%	24.4%
Low	-	-99.1%

EPS Forecast

EPS	2026	2027
High	0.02	0.13
Avg	-0.03	-0.00
Low	-0.06	-0.07

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.